Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
21 May 2021
Historique:
received: 21 04 2021
revised: 10 05 2021
accepted: 14 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 9 6 2021
Statut: epublish

Résumé

Calcifediol has been proposed as a potential treatment for COVID-19 patients. To compare the administration or not of oral calcifediol on mortality risk of patients hospitalized because of COVID-19. Retrospective, multicenter, open, non-randomized cohort study. Hospitalized care. Patients with laboratory-confirmed COVID-19 between 5 February and 5 May 2020 in five hospitals in the South of Spain. Patients received calcifediol (25-hydroxyvitamin D In-hospital mortality during the first 30 days after admission. A total of 537 patients were hospitalized with COVID-19 (317 males (59%), median age, 70 years), and 79 (14.7%) received calcifediol treatment. Overall, in-hospital mortality during the first 30 days was 17.5%. The OR of death for patients receiving calcifediol (mortality rate of 5%) was 0.22 (95% CI, 0.08 to 0.61) compared to patients not receiving such treatment (mortality rate of 20%; Among patients hospitalized with COVID-19, treatment with calcifediol, compared with those not receiving calcifediol, was significantly associated with lower in-hospital mortality during the first 30 days. The observational design and sample size may limit the interpretation of these findings.

Identifiants

pubmed: 34064175
pii: nu13061760
doi: 10.3390/nu13061760
pmc: PMC8224356
pii:
doi:

Substances chimiques

Calcifediol P6YZ13C99Q

Types de publication

Clinical Trial Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA. 2018 Feb 20;319(7):698-710
pubmed: 29466596
Ir Med J. 2020 May 07;113(5):81
pubmed: 32603576
Aging (Albany NY). 2020 Dec 22;12(24):24522-24534
pubmed: 33353888
J Steroid Biochem Mol Biol. 2018 Mar;177:266-269
pubmed: 28842142
J Steroid Biochem Mol Biol. 2021 Jul;211:105901
pubmed: 33864925
FEBS J. 2020 Sep;287(17):3693-3702
pubmed: 32700398
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
PLoS One. 2014 Feb 28;9(2):e90301
pubmed: 24587317
Postgrad Med J. 2020 Nov 12;:
pubmed: 33184146
Aging Clin Exp Res. 2020 Jul;32(7):1195-1198
pubmed: 32377965
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Osteoporos Int. 2018 Aug;29(8):1697-1711
pubmed: 29713796
Clin Biochem. 2008 Jun;41(9):676-80
pubmed: 18313404
Nutrients. 2020 May 09;12(5):
pubmed: 32397511
JBMR Plus. 2020 Nov 10;4(12):e10417
pubmed: 33354643
Mol Med Rep. 2016 Feb;13(2):1186-94
pubmed: 26675943
PLoS One. 2020 Sep 17;15(9):e0239252
pubmed: 32941512
PLoS One. 2019 Apr 12;14(4):e0215383
pubmed: 30978243
Korean J Intern Med. 2018 Nov;33(6):1129-1136
pubmed: 29914229
Int J Infect Dis. 2021 Jan;102:196-202
pubmed: 33129966
Eur J Endocrinol. 2020 Nov;183(5):R133-R147
pubmed: 32755992
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Nutr Rev. 2014 Jan;72(1):48-54
pubmed: 24330136
BMJ. 2020 Sep 4;370:m3379
pubmed: 32887691
J Steroid Biochem Mol Biol. 2013 Jul;136:175-7
pubmed: 23142144
J Steroid Biochem Mol Biol. 2020 Sep;202:105719
pubmed: 32535032
N Engl J Med. 2021 Jan 21;384(3):229-237
pubmed: 33113295
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
Thorax. 2015 Jul;70(7):617-24
pubmed: 25903964
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Metabolism. 2021 Feb;115:154434
pubmed: 33217408
Endocr Rev. 2019 Aug 1;40(4):1109-1151
pubmed: 30321335
Thorax. 2003 May;58(5):377-82
pubmed: 12728155
JAMA Netw Open. 2020 Sep 1;3(9):e2019722
pubmed: 32880651
Nutrients. 2020 Sep 10;12(9):
pubmed: 32927735
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1343-e1353
pubmed: 33159440
Bone. 2014 Feb;59:14-9
pubmed: 24516879
BMJ Open Respir Res. 2015 Jun 13;2(1):e000074
pubmed: 26113982
Physiol Rep. 2021 Feb;9(3):e14747
pubmed: 33580636
N Engl J Med. 2021 Mar 4;384(9):795-807
pubmed: 33306283
JAMA Netw Open. 2021 Mar 1;4(3):e214117
pubmed: 33739433
J Bone Miner Res. 2019 Nov;34(11):1985-1992
pubmed: 31589774
J Steroid Biochem Mol Biol. 2016 Nov;164:205-208
pubmed: 26829558
Biochem Pharmacol. 2020 Jul;177:113955
pubmed: 32251673
J Clin Pathol. 2013 Jul;66(7):620-2
pubmed: 23454726
JAMA. 2021 Mar 16;325(11):1053-1060
pubmed: 33595634
Nutrients. 2020 Nov 02;12(11):
pubmed: 33147894
Lancet Diabetes Endocrinol. 2020 Sep;8(9):735-736
pubmed: 32758429
Am J Respir Crit Care Med. 2020 Aug 1;202(3):371-382
pubmed: 32186892
Mol Med Rep. 2017 Nov;16(5):7432-7438
pubmed: 28944831
Nutrients. 2020 Dec 11;12(12):
pubmed: 33322317
Crit Care. 2011;15(2):R104
pubmed: 21443793
Nutrients. 2020 Apr 02;12(4):
pubmed: 32252338
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Science. 2020 Sep 4;369(6508):1210-1220
pubmed: 32788292
J Steroid Biochem Mol Biol. 2020 Nov;204:105771
pubmed: 33065275
PLoS One. 2020 Sep 25;15(9):e0239799
pubmed: 32976513
Int Immunopharmacol. 2021 Apr 17;97:107686
pubmed: 33930705
Crit Rev Food Sci Nutr. 2020 Nov 4;:1-9
pubmed: 33146028
J Steroid Biochem Mol Biol. 2020 Oct;203:105751
pubmed: 32871238
J Immunol. 2008 Nov 15;181(10):7090-9
pubmed: 18981129
Mol Endocrinol. 2013 Dec;27(12):2116-25
pubmed: 24196349

Auteurs

Juan F Alcala-Diaz (JF)

Internal Medicine Department, IMIBIC/Reina Sofia University Hospital/University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
CIBER Fisiopatologia Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Laura Limia-Perez (L)

Internal Medicine Department, IMIBIC/Reina Sofia University Hospital/University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.

Ricardo Gomez-Huelgas (R)

Internal Medicine Department, Regional University Hospital of Málaga, Avenida de Carlos Haya, s/n, 29010 Málaga, Spain.
Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Avenida de Carlos Haya, s/n, 29010 Málaga, Spain.

Maria D Martin-Escalante (MD)

Internal Medicine Department, Hospital Costa del Sol, Agencia Sanitaria Costa del Sol, 29603 Marbella, Málaga, Spain.

Begoña Cortes-Rodriguez (B)

Internal Medicine Department, Alto Guadalquivir Hospital, Andújar, 23740 Jaén, Spain.

Jose L Zambrana-Garcia (JL)

Internal Medicine Department, Hospital de Montilla, Agencia Sanitaria Alto Guadalquivir, 14550 Córdoba, Spain.

Marta Entrenas-Castillo (M)

Pneumology Department, Reina Sofia University Hopital. Avda, Menendez Pidal s/n, 14004 Córdoba, Spain.

Ana I Perez-Caballero (AI)

Internal Medicine Department, IMIBIC/Reina Sofia University Hospital/University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
CIBER Fisiopatologia Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Maria D López-Carmona (MD)

Internal Medicine Department, Regional University Hospital of Málaga, Avenida de Carlos Haya, s/n, 29010 Málaga, Spain.
Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Avenida de Carlos Haya, s/n, 29010 Málaga, Spain.

Javier Garcia-Alegria (J)

Internal Medicine Department, Hospital Costa del Sol, Agencia Sanitaria Costa del Sol, 29603 Marbella, Málaga, Spain.
Department of Medicine, University of Málaga (UMA), Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), 29071 Málaga, Spain.

Aquiles Lozano Rodríguez-Mancheño (A)

Internal Medicine Department, Alto Guadalquivir Hospital, Andújar, 23740 Jaén, Spain.

Maria Del Sol Arenas-de Larriva (MDS)

Pneumology Department, Reina Sofia University Hopital. Avda, Menendez Pidal s/n, 14004 Córdoba, Spain.

Luis M Pérez-Belmonte (LM)

Internal Medicine Department, Regional University Hospital of Málaga, Avenida de Carlos Haya, s/n, 29010 Málaga, Spain.
Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Avenida de Carlos Haya, s/n, 29010 Málaga, Spain.

Irwin Jungreis (I)

MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA 02139, USA.
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Roger Bouillon (R)

Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Herestraat, ON 1/902, 3000 Leuven, Belgium.

Jose Manual Quesada-Gomez (JM)

IMIBIC. CIBER de Fragilidad y Envejecimiento Saludable, Hospital Universitario Reina Sofía, Universidad de Córdoba, Fundación Progreso y Salud, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.

Jose Lopez-Miranda (J)

Internal Medicine Department, IMIBIC/Reina Sofia University Hospital/University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
CIBER Fisiopatologia Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH